PLK1 and cancer: The model linked BI 2536 sensitivity with the target PLK1, which is known to be critical for the growth of MDA-MB-231 and many other cancer cell lines.20 In summary, these results demonstrated that the data-driven drug combination network model can accurately prioritize potent combinations as well as suggest their underlying target interactions for further experimentation.